Details of the Target
General Information of Target
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C87(3.83) | LDD3397 | [1] | |
IA-alkyne Probe Info |
![]() |
N.A. | LDD0166 | [2] | |
Lodoacetamide azide Probe Info |
![]() |
N.A. | LDD0037 | [3] |
Competitor(s) Related to This Target
The Interaction Atlas With This Target
The Protein(s) Related To This Target
Transporter and channel
Protein name | Family | Uniprot ID | |||
---|---|---|---|---|---|
Myelin and lymphocyte protein (MAL) | MAL family | P21145 | |||
Peripheral myelin protein 22 (PMP22) | PMP-22/EMP/MP20 family | Q01453 | |||
Transmembrane protein 203 (TMEM203) | . | Q969S6 |
Other
The Drug(s) Related To This Target
Approved
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Muromonab | BiotechDrug | DB00075 | |||
Teclistamab | . | DB16655 |
Phase 3
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Teplizumab | Antibody | D0VH4V |
Phase 2
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Ertumaxomab | Antibody | D0O2JI | |||
Imcgp100 | Monoclonal antibody | D0S0BJ | |||
Mgd007 | Monoclonal antibody | D00PEN |
Phase 1
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Autologous T-cell Therapy | Antibody | D04UWG | |||
Mt-110 | Antibody | D00YOV | |||
Medi-565 | Monoclonal antibody | D0PY3L |
Investigative
Drug Name | Drug Type | External ID | |||
---|---|---|---|---|---|
Odronextamab | . | DB16684 |
References